LithoVue
Device LithoVue_URO
PDI 08714729874522
General payments
$457,312
Research payments
$14,430
Through program year 2025, $457,312 in general payments and $14,430 in research payments were reported against LithoVue (LithoVue_URO).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $90,033 | 1,698 |
| 2024 | General | $148,560 | 1,962 |
| 2024 | Research | $14,430 | 4 |
| 2023 | General | $115,197 | 1,889 |
| 2022 | General | $103,330 | 1,367 |
| 2021 | General | $193 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 55 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 47 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
6,917 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.